Sex-based differences in antibody-mediated rejection among highly sensitized kidney transplant recipients

Clicks: 10
ID: 332983
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #196 of 209 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 209 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Antibody-mediated rejection (AMR) remains a major determinant of graft failure in kidney transplantation, particularly among highly sensitized recipients. Whether biological sex independently influences the incidence and determinants of AMR in this high-risk population remains uncertain. We hypothesized that recipient sex may be associated with early AMR risk beyond conventional immunologic risk factors. We therefore evaluated the association between sex and early AMR, explored sex-specific immunologic determinants, and assessed the impact of AMR on long-term graft survival. Methods We performed a multicenter retrospective cohort study of 438 highly sensitized deceased-donor kidney transplant recipients with cPRA ≥ 90% transplanted in Catalonia, Spain, between 2015 and 2021. The primary outcome was AMR within the first post-transplant year. Secondary outcomes included five-year death-censored graft survival and sex-specific associations with AMR. Median follow-up was 42.5 months. Results Within the first year, 51 recipients (11.6%) developed AMR. Men exhibited a higher incidence of AMR compared with women (16.2% vs. 8.5%; P = 0.01). In sex-stratified analyses, antibody strength was the dominant determinant in men, whereas DQB1 eplet mismatch was more strongly associated with AMR in women, although formal interaction testing was not statistically significant. AMR occurring within the first year was the strongest predictor of five-year graft failure (HR 8.3; P < 0.001), while recipient sex was not independently associated with graft loss. Conclusions In highly sensitized recipients, male sex was modestly associated with early rejection. AMR emerged as the main driver of long-term graft loss. The impact of epitope-level HLA mismatch on AMR risk may differ between sexes, particularly at the HLA-DQB1 locus, and warrants further investigation.
Reference Key
openalex_W7222984205 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Evelyn Hermida, Carolt Arana, Jordi Rovira, Edoardo Melilli, Francesc Moreso, Marta Crespo, Carme Facundo, Anna Vila-Santandreu, M. J. Perez-Saez, Alexandre Favà, Cinthia Baldallo, Cristina CANAL, Javier Paúl-Martínez, Jordi Comas, Jaume Tort, Eduard Palou, Fritz Diekmann, Pedro Ventura‐Aguiar
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag367
URL
https://doi.org/10.1093/ckj/sfag367
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.